Potential deleterious role of anti‐Neu5Gc antibodies in xenotransplantation. (13th October 2014)

• Record Type: Journal Article
• Authors: Salama, Apolline; Evanno, Gwénaëlle; Harb, Jean; Soulillou, Jean‐Paul
• Is Part Of: Xenotransplantation. Volume 22:Number 2(2015:Mar./Apr.)
• Page Start: 85
• Page End: 94
• Publication Date: 2014-10-13
• Subjects: Xenografts -- Periodicals; Transplantation of organs, tissues, etc -- Periodicals; 617.95
• DOI: 10.1111/xen.12142
• Languages: English
• ISSNs: 0908-665X

Abstract

<abstract abstract-type="main" id="xen12142-abs-0001"> <title>Abstract</title> <p>Human beings do not synthesize the glycolyl form of the sialic acid (Neu5Gc) and only express the acetylated form of the sugar, whereas a diet‐based intake of Neu5Gc provokes a natural immunization and production of anti‐Neu5Gc antibodies in human serum. However, Neu5Gc is expressed on mammal glycoproteins and glycolipids in most organs and cells. We review here the relevance of Neu5Gc and anti‐Neu5Gc antibodies in the context of xenotransplantation and the use of animal‐derived molecules and products, as well as the possible consequences of a long‐term exposure to anti‐Neu5Gc antibodies in recipients of xenografts. In addition, the importance of an accurate estimation of the anti‐Neu5Gc response following xenotransplantation and the future contribution of knockout animals mimicking the human situation are also assessed.</p> </abstract>